Cornell University
Library
Cornell UniversityLibrary

eCommons

Help
Log In(current)
  1. Home
  2. Weill Cornell Medicine
  3. Medical College Research and Papers
  4. Department of Healthcare Policy & Research
  5. Second primary cancer in breast cancer survivors by race/ethnicity and Asian subgroups: a descriptive epidemiologic study

Second primary cancer in breast cancer survivors by race/ethnicity and Asian subgroups: a descriptive epidemiologic study

Access Restricted

Access to this document is restricted. Some items have been embargoed at the request of the author, but will be made publicly available after the "No Access Until" date.

During the embargo period, you may request access to the item by clicking the link to the restricted file(s) and completing the request form. If we have contact information for a Cornell author, we will contact the author and request permission to provide access. If we do not have contact information for a Cornell author, or the author denies or does not respond to our inquiry, we will not be able to provide access. For more information, review our policies for restricted content.

File(s)
41437642.pdf (1.54 MB)
No Access Until
2027-05-01
Permanent Link(s)
https://hdl.handle.net/1813/124325
Collections
Department of Healthcare Policy & Research
Author
Shao, L.
Wang, Y.
Shieh, Y.
Tamimi, R.M.
Ju, T.
Choi, E.
Abstract

BACKGROUND: Treatment advances have improved breast cancer survival, resulting in a growing population at risk for second primary cancers (SPCs). Although prior studies suggest racial heterogeneity in SPC risk, little is known about SPC patterns among diverse Asian American subgroups. Post-SPC survival outcomes by race/ethnicity and Asian subgroups remain underexplored. METHODS: We identified women with stage I-III breast cancer diagnosed between 2010-2020 in SEER. Primary outcomes included cumulative SPC incidence and post-SPC survival, stratified by race/ethnicity (Asian, Black, Hispanic, Pacific Islander, and White) and Asian subgroups (Chinese, Filipino, Indian/Pakistani, Japanese, Korean, Vietnamese). Cox models assessed the association between SPC and overall survival, treating SPC as a time-varying covariate to address immortal time bias. RESULTS: Among 430,823 survivors, 5-year SPC incidence was highest in White (6.2%, [6.1-6.3]) and lowest in Pacific Islander survivors (4.2%, [3.7-4.7]). Disaggregating Asian subgroups revealed notable heterogeneity Chinese survivors had the highest incidence (5.4%, [4.8-6.1]) and Indian/Pakistani survivors the lowest (3.7%, [2.9-4.4]). SPC development was associated with increased risk of mortality (adjusted hazard ratio [aHR]=3.85, [3.73-3.98]). The magnitude of this association was most pronounced among Pacific Islander (aHR = 5.85) and least among White survivors (aHR = 3.68; interaction P < .001). Within Asian subgroups, the effect was strongest in Vietnamese (aHR = 7.93) and attenuated in Korean survivors (aHR = 3.45; interaction P = .13). CONCLUSIONS: White and Chinese survivors had the highest SPC risk, while Pacific Islander and Vietnamese survivors faced greater mortality impact from SPCs. Racially disaggregated analyses revealed heterogeneity, underscoring the need for tailored care in the diverse U.S. breast cancer survivor population.

Journal / Series
Journal of the National Cancer Institute
Volume & Issue
118(5)
Date Issued
2026-05-01
Publisher
Oxford University Press
Keywords
WCM Library Coordinated Deposit
•
Humans
•
Female
•
Breast Neoplasms/epidemiology/pathology/mortality/ethnology
•
Neoplasms, Second Primary/epidemiology/ethnology/mortality
•
Middle Aged
•
Cancer Survivors/statistics & numerical data
•
SEER Program/statistics & numerical data
•
Aged
•
Incidence
•
Asian/statistics & numerical data
•
United States/epidemiology
•
Adult
•
Ethnicity/statistics & numerical data
Related DOI
https://doi.org/10.1093/jnci/djaf372
Previously Published as
Shao L, Wang Y, Shieh Y, Tamimi RM, Ju T, Choi E. Second primary cancer in breast cancer survivors by race/ethnicity and Asian subgroups: a descriptive epidemiologic study. Journal of the National Cancer Institute. 2026;118(5):883-891. doi: 10.1093/jnci/djaf372. PMID: 41437642.
Rights
Attribution-NonCommercial-NoDerivatives 4.0 International
Rights URI
https://creativecommons.org/licenses/by-nc-nd/4.0/
Type
article

Site Statistics | Help

About eCommons | Policies | Terms of use | Contact Us

copyright © 2002-2026 Cornell University Library | Privacy | Web Accessibility Assistance